स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
felkarid 100 mg tablete
flekainidijev acetat - tableta - flekainidijev acetat 100 mg / 1 tableta - flekainid
स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
felkarid 50 mg tablete
flekainidijev acetat - tableta - flekainidijev acetat 50 mg / 1 tableta - flekainid
स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
flekainidijev acetat 20 mg/ml peroralna suspenzija
flekainidijev acetat - peroralna raztopina - flekainidijev acetat 20 mg / 1 ml - flekainid
स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
tambocor 100 mg tablete
sanolabor, d.d. - flekainid - tableta - flekainid 100 mg / 1 tableta - flekainid
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplazem, kastracija-odporne - antineoplastična sredstva - treatment of adult patients with prostate cancer.
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
agenerase
glaxo group ltd. - amprenavir - okužbe z virusom hiv - antivirusi za sistemsko uporabo - zdravilo agenerase, v kombinaciji z drugimi protiretrovirusnimi zdravili, je indicirano za zdravljenje zaviralcev proteaze (pi), ki so se doživeli odrasli in otroci, okuženi s hiv-1, in njihovi otroci, starejši od 4 let. kapsule agenerase je običajno treba dajati z majhnim odmerkom ritonavirja kot farmakokinetičnega povečevalnika amprenavirja (glejte poglavja 4. 2 in 4. izbira amprenavirja mora temeljiti na testiranju odpornosti na posamezne virusne odmerke in zgodovini zdravljenja bolnikov (glejte poglavje 5). koristi agenerase razširila z ritonavir ni bila dokazana v pi ladjo bolnikih (glejte poglavje 5.
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
abiraterone mylan
mylan ireland limited - abirateron acetat - prostatične neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
यूरोपीय संघ -
स्लोवेनियाई -
EMA (European Medicines Agency)
abiraterone krka
krka, d.d., novo mesto - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
amjodaron hameln 20 mg/ml raztopina za infundiranje
amjodaron - raztopina za infundiranje - amjodaron 18,93 mg / 1 ml - amjodaron
स्लोवेनिया -
स्लोवेनियाई -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
amjodaron hameln 50 mg/ml koncentrat za raztopino za injiciranje/infundiranje
amjodaron - koncentrat za raztopino za injiciranje/infundiranje - amjodaron 46,9 mg / 1 ampula - amjodaron